医学全在线
搜索更多精品课程:
热 门:外科内科学妇产科儿科眼科耳鼻咽喉皮肤性病学骨科学全科医学医学免疫学生理学病理学诊断学急诊医学传染病学医学影像药 学:药理学药物化学药物分析药物毒理学生物技术制药生药学中药学药用植物学方剂学卫生毒理学检 验:理化检验 临床检验基础护 理:外科护理妇产科护理儿科护理 社区护理五官护理护理学内科护理护理管理学中 医:中医基础理论中医学针灸学刺法灸法学口 腔:口腔内科口腔外科口腔正畸口腔修复口腔组织病理生物化学:生物化学细胞生物学病原生物学医学生物学分析化学医用化学其 它:人体解剖学卫生统计学人体寄生虫学仪器分析健康评估流行病学临床麻醉学社会心理学康复医学法医学核医学危重病学中国医史学
您现在的位置: 医学全在线 > 精品课程 > 药理学 > 南华大学 > 正文:药理学授课教案:第二十三章 肾素-血管紧张素系统药理
    

药理学授课教案-第四篇 心血管系统药理:第二十三章 肾素-血管紧张素系统药理

药理学授课教案第四篇 心血管系统药理:第二十三章 肾素-血管紧张素系统药理:生命科学与技术学院教 案 首 页教研室:药理学教师姓名:欧和生 课 程名 称 药理学 授课专业及班次 临床医学专业 授课内 容 肾素-血管紧张素系统药理 授课方式 授课时数 理论讲授 2学时 目 的 要 求 1. 熟悉肾素-血管紧张素系统对心血管系统的生理机制。 2.

生命科学与技术学院

教 案 首 页

教研室:药理学  教师姓名:欧和生

课 程名 称

药理学

授课专业及班次

临床医学专业

授课内 容

肾素-血管紧张素系统药理

授课方式

授课时数

理论讲授

2学时

1. 熟悉肾素-血管紧张素系统对心血管系统的生理机制。
2. 掌握ACEI和血管紧张素II受体I型阻滞剂的药理作用及其机制。
3. 掌握卡托普利氯沙坦的药理作用、临床应用及主要不良反应。

重点

1. ACEI和血管紧张素II受体I型阻滞剂的药理作用及其机制。

2. 托普利和氯沙坦等药物的药理作用、临床应用。

难点

肾素-血管紧张素系统对心血管系统调节的生理机制及药物作用机制。

授课内容及时间分配

1.   Renin-Aangiotensin-System (20 分钟)

2.   Angiotensin converting enzyme inhibitors (ACEI) (45分钟)

3.   The blockade of angiotension II receptor (20 分钟)

4.   小结、布置思考题、安排下次课内容 (5分钟)

教具教材

多媒体加版书

教材:杨宝峰 主编:药理学 人民卫生出版社,北京,2003年

1.  周宏灏主编:药理学 科学出版社,北京,2003年

2.  Pharmacology : 天津医科大学药理教研室主编,1999年

3.  H.P. Rang, M.M Dale, J.M. Ritter P.K. Moore. Pharmacology ( the fifth edition). 2003.


Part 1  Renin-Aangiotensin-System

 

Introduction

1.Element of RAS (renin, angiotensinogen,angiotensin, ACE, ATR)

Renin is an enzyme that acts on angiotensinogen to catalyze the formation of the decapeptide angiotensin I.

Angiotensin I is then cleaved by ACE to yield the octapeptide angiotensin II.

ATR: AT1R, AT2R

2.The regulation effect of RAS on blood pressure

The renin-angiotensinsystem is an important participant in both the short-and long-term regulationof arterial blood pressure.

Angiotensin II acts in several ways to increase totalperipheral resistance and thereby contributes to the short-term regulation ofarterial blood pressure. Perhaps the more important is the ability of angiotensin II to inhibit excretion of Na+ and water by thekidneys.

Angiotensin II – induced changes in renal functionplay an important role in long-term stabilization of arterial blood pressure.

Part 2  Angiotensinconverting enzyme inhibitors (ACEI)

1.Pharmacological effects

(1) Inhibit the formation of Ang II.

 (2) Maintain the activity of brandykinin (BK).

 (3) Protection of endothelium andanti-atherosclerosis

 (4) Anti-iscamiaand protection of myocardial cell

 (5) Increase the sensitivity of insulin

(6) Inhibit the pathological cardiovascular remodeling

2. Clinical uses

(1) Hypertension

(2) CHF and myocardial infarction

(3) DMEM and nephropathy

3. Untoward effects

(1) Hypotension: occurring in the first use.

(2) Cough: of 6 ~ 12%

(3) Hyperkalemia

(4) Low blood sugar

(5) Renal function trauma

(6) Affection of the development of fetus and newborn.

(7) Neuro Oedema.

(8) Malfunction of taste, tetter (thedrugs with –SH).

4.The drugs of ACEI.

. Captopril

Pharmacological Action :

 i  Directly inhibited ACE. (IC50:23 ~ 35 nmol /L), The depressor effect associated with the activitystate of RAS.

ii   The protection of heart is relatedto abolishing of ROS, such as iscamia.

Pharmacokinetics

o  Absorption : Po, F=75%. Taction :30 min. Tmax=1h.

o  Distribution: extensivelydistributed in body , Pb=30%.

o  Metabolism: oxygen in –SH.

o  Excretion: from kidney: 40-50%in parent drug and the others in metabolites.

Clinical uses

o  Hypertension: single or combination.

o  CHF

o  Cardiac infarct.

o  DMEM-nephropathy (only captopril).

Untoward effects

Apart fromthe common side effect, cough is usually complaint.

Enalapril

o  Action : the action of inhibition of ACE is 10 times stronger than captopril.

o  The absorption is not affectedby food. Po. TP=4-6h.  Tmaintain=24h,q.d.

o  Metabolism: enalaprilat(MK22)

o  Distribution extensively inbody. T1/2: 11h.

o  Excretion from kidney.

o  Uses: hypertensionwww.med126.com/sanji/ and CHF.

o  Aside effect: cough ,hypotension, hyperkalemiaetc.

Fosinopril

o  Prodrug (poo-): fosinoprilacid is the activity chemical.

o  Tp=3-6 h

o  Pb=95%

o&www.med126.com/kuaiji/nbsp; T1/2=12h

o  Distribution : heart and brain(much)

o  Excretion: from liver and kidney,  no toxicityaccumulation for light malfunction of kidney.

o  No use:lactation

Lisinopril

benazepril

Part 3  The blockade of angiotension II receptor

losartan、valsartan、erbesartan、candesartan、tasosartan、eprosartan、telmisartan

1. Pharmacological effects and mechanism

 (1) Block the AT1R   vasodilatation 

     Aldostrone  Hypotension

 


(2) Block theAT1R Renin  AngII AT2RBK-NO 

Vasodilatation, regression of remodeling Hypotension.

Losartan

1.Pharmacological effects

(1)AT1R: Losartan block AT1R>AT2R (2-3万倍).   EXP3174 >losartanin  blocking  AT1R  (10- 40 times)

(2)Vasodilate renalartery, decrease reabsorption of water and Na+in renal tube.

(3)Protect kidney:Hypertension,DM and failure of kidney.

(4)Inhibit vascular remodeling.

2. Clinical uses

 (1) Hypertension

 (2)CHF

3. Untoward effects: less than ACEI, avoid use with low efficacy diuretics.

Part 4 Howabout combination of AT1Ranta and ACEI

  1. Increase effects(cure in hypertension, CHF), decrease disadvantage of the two class drugs.

  2. Have not found anyadverse effects

Questions:

1. Describe the advantages anddisadvantages of AT1R and ACEI in therapeutics of hypertension.

2. what is thecommon side effect of Captopril?

...
关于我们 - 联系我们 -版权申明 -诚聘英才 - 网站地图 - 医学论坛 - 医学博客 - 网络课程 - 帮助
医学全在线 版权所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
皖ICP备06007007号
百度大联盟认证绿色会员可信网站 中网验证